Why the study?
Does nitrendipine improve recovery of contractile function following coronary artery occlusion and reperfusion in conscious dogs?
Does nitrendipine improve recovery of contractile function following coronary artery occlusion and reperfusion in conscious dogs?
Pretreatment with the calcium channel blocker nitrendipine enhances the recovery of contractile function in postischemic, reperfused, stunned myocardium in a canine model.
Supports experimental use of calcium channel blockade in myocardial stunning; leaves open translation to clinical reperfusion.
The effect of the new calcium channel blocking agent, nitrendipine, on recovery of contractile function following a 10-min left anterior descending coronary artery occlusion was studied in conscious dogs instrumented with sonomicrometers in the subendocardium of ischemic and normal regions. Nitrendipine (1.0 and 2.5 micrograms/kg/min i.v.) or drug vehicle was administered 30 min prior to the onset of coronary artery occlusion and continued for 30 min following reperfusion accomplished by inflation and deflation of a vascular balloon cuff. Nitrendipine produced a dose-related reduction in arterial pressure and an increase in heart rate and left circumflex coronary blood flow velocity. At 6 h following reperfusion in control dogs (N = 8), segment shortening was significantly reduced from control levels (71 +/- 10% of control). In comparison, dogs pretreated with nitrendipine (3 micrograms/kg/min i.v.) (n = 8) had significantly greater recovery of segment shortening throughout the reperfusion period (102 +/- 10% of control at 6 h following reperfusion). The data demonstrate that pretreatment with the calcium channel blocking agent enhances the recovery of function in postischemic, reperfused, "stunned" myocardium.
No takes yet. Share an insight, caveat, or question.
Warltier et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: